A tighter archive for life-science signals.
Search once, then narrow by source or topic.
How Investors May Respond To 10x Genomics (TXG) Patent Invalidation in Advanced Genomics Tools - Yahoo Finance
How Investors May Respond To 10x Genomics (TXG) Patent Invalidation in Advanced Genomics Tools Yahoo Finance
Ultima Genomics UG 100 platform vs. Illumina NovaSeq X Series whole-genome sequencing benchmarking - Illumina
Ultima Genomics UG 100 platform vs. Illumina NovaSeq X Series whole-genome sequencing benchmarking Illumina
Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma
Lonza Expands Cell and Gene Therapy Portfolio Contract Pharma
Bioindustry Faces Talent Crunch and Regulatory Strain - GEN - Genetic Engineering and Biotechnology News
Bioindustry Faces Talent Crunch and Regulatory Strain GEN - Genetic Engineering and Biotechnology News
Agrigenomics arrays and consortia | Collaborating with experts - Illumina
Agrigenomics arrays and consortia | Collaborating with experts Illumina
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development GEN - Genetic Engineering and Biotechnology News
Leveraging illumina iSeq100 for whole genome sequencing of Salmonella Typhi for a resource-limited setting - Nature
Leveraging illumina iSeq100 for whole genome sequencing of Salmonella Typhi for a resource-limited setting Nature
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics GEN - Genetic Engineering and Biotechnology News
Illumina sued by rival Element over gene-sequencing technology - Reuters
Illumina sued by rival Element over gene-sequencing technology Reuters
Top 10 Contract Development and Manufacturing Organizations 2025 - GEN - Genetic Engineering and Biotechnology News
Top 10 Contract Development and Manufacturing Organizations 2025 GEN - Genetic Engineering and Biotechnology News
Bioprocess 5.0: Straddles the Human-AI Divide to Scale Next-Gen Therapies - GEN - Genetic Engineering and Biotechnology News
Bioprocess 5.0: Straddles the Human-AI Divide to Scale Next-Gen Therapies GEN - Genetic Engineering and Biotechnology News
Process Monitors and Controls Shift Towards Unified Platforms - GEN - Genetic Engineering and Biotechnology News
Process Monitors and Controls Shift Towards Unified Platforms GEN - Genetic Engineering and Biotechnology News
Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development - BioSpectrum Asia
Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development BioSpectrum Asia
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility - Nutritional Outlook
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility Nutritional Outlook
Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
Lonza CHI receives NutraStrong Collagen Verified certification nutritioninsight.com
Manufacturing Challenges with High-Concentration Biologics - GEN - Genetic Engineering and Biotechnology News
Manufacturing Challenges with High-Concentration Biologics GEN - Genetic Engineering and Biotechnology News
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients - Nutraceutical Business Review
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients Nutraceutical Business Review
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands - PR Newswire
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands PR Newswire
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page